174 related articles for article (PubMed ID: 10579797)
1. Androgen-independent growth is induced by neuropeptides in human prostate cancer cell lines.
Jongsma J; Oomen MH; Noordzij MA; Romijn JC; van Der Kwast TH; Schröder FH; van Steenbrugge GJ
Prostate; 2000 Jan; 42(1):34-44. PubMed ID: 10579797
[TBL] [Abstract][Full Text] [Related]
2. The human prostatic cancer cell line LNCaP and its derived sublines: an in vitro model for the study of androgen sensitivity.
van Steenbrugge GJ; van Uffelen CJ; Bolt J; Schröder FH
J Steroid Biochem Mol Biol; 1991; 40(1-3):207-14. PubMed ID: 1958522
[TBL] [Abstract][Full Text] [Related]
3. Bombesin specifically induces intracellular calcium mobilization via gastrin-releasing peptide receptors in human prostate cancer cells.
Aprikian AG; Han K; Chevalier S; Bazinet M; Viallet J
J Mol Endocrinol; 1996 Jun; 16(3):297-306. PubMed ID: 8782088
[TBL] [Abstract][Full Text] [Related]
4. Characterization of high-affinity receptors for bombesin/gastrin releasing peptide on the human prostate cancer cell lines PC-3 and DU-145: internalization of receptor bound 125I-(Tyr4) bombesin by tumor cells.
Reile H; Armatis PE; Schally AV
Prostate; 1994 Jul; 25(1):29-38. PubMed ID: 8022709
[TBL] [Abstract][Full Text] [Related]
5. [Effect of the neuropeptides bombesin and calcitonin on the growth of prostate cell lines, PC-3, DU 145, and LNCaP].
Larrán López J; Aparicio Patino J; López Muñoz A; Vilches Troya J
Actas Urol Esp; 2000; 24(10):779-84. PubMed ID: 11199293
[TBL] [Abstract][Full Text] [Related]
6. Different profiles of neuroendocrine cell differentiation evolve in the PC-310 human prostate cancer model during long-term androgen deprivation.
Jongsma J; Oomen MH; Noordzij MA; Van Weerden WM; Martens GJ; van der Kwast TH; Schröder FH; van Steenbrugge GJ
Prostate; 2002 Mar; 50(4):203-15. PubMed ID: 11870798
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms of androgen-independent growth of human prostate cancer LNCaP-AI cells.
Lu S; Tsai SY; Tsai MJ
Endocrinology; 1999 Nov; 140(11):5054-9. PubMed ID: 10537131
[TBL] [Abstract][Full Text] [Related]
8. Antagonists of growth hormone releasing hormone (GHRH) and of bombesin/gastrin releasing peptide (BN/GRP) suppress the expression of VEGF, bFGF, and receptors of the EGF/HER family in PC-3 and DU-145 human androgen-independent prostate cancers.
Stangelberger A; Schally AV; Varga JL; Hammann BD; Groot K; Halmos G; Cai RZ; Zarandi M
Prostate; 2005 Aug; 64(3):303-15. PubMed ID: 15754342
[TBL] [Abstract][Full Text] [Related]
9. The novel antimicrotubule agent cryptophycin 52 (LY355703) induces apoptosis via multiple pathways in human prostate cancer cells.
Drew L; Fine RL; Do TN; Douglas GP; Petrylak DP
Clin Cancer Res; 2002 Dec; 8(12):3922-32. PubMed ID: 12473608
[TBL] [Abstract][Full Text] [Related]
10. Variants of the human prostate LNCaP cell line as tools to study discrete components of the androgen-mediated proliferative response.
Soto AM; Lin TM; Sakabe K; Olea N; Damassa DA; Sonnenschein C
Oncol Res; 1995; 7(10-11):545-58. PubMed ID: 8866667
[TBL] [Abstract][Full Text] [Related]
11. Aberrant activation of androgen receptor in a new neuropeptide-autocrine model of androgen-insensitive prostate cancer.
Yang JC; Ok JH; Busby JE; Borowsky AD; Kung HJ; Evans CP
Cancer Res; 2009 Jan; 69(1):151-60. PubMed ID: 19117998
[TBL] [Abstract][Full Text] [Related]
12. Androgen deprivation of the PC-310 [correction of prohormone convertase-310] human prostate cancer model system induces neuroendocrine differentiation.
Jongsma J; Oomen MH; Noordzij MA; Van Weerden WM; Martens GJ; van der Kwast TH; Schröder FH; van Steenbrugge GJ
Cancer Res; 2000 Feb; 60(3):741-8. PubMed ID: 10676662
[TBL] [Abstract][Full Text] [Related]
13. Melatonin and prostate cancer cell proliferation: interplay with castration, epidermal growth factor, and androgen sensitivity.
Siu SW; Lau KW; Tam PC; Shiu SY
Prostate; 2002 Jul; 52(2):106-22. PubMed ID: 12111702
[TBL] [Abstract][Full Text] [Related]
14. Vasoactive intestinal peptide transactivates the androgen receptor through a protein kinase A-dependent extracellular signal-regulated kinase pathway in prostate cancer LNCaP cells.
Xie Y; Wolff DW; Lin MF; Tu Y
Mol Pharmacol; 2007 Jul; 72(1):73-85. PubMed ID: 17430995
[TBL] [Abstract][Full Text] [Related]
15. Neuropeptide-induced androgen independence in prostate cancer cells: roles of nonreceptor tyrosine kinases Etk/Bmx, Src, and focal adhesion kinase.
Lee LF; Guan J; Qiu Y; Kung HJ
Mol Cell Biol; 2001 Dec; 21(24):8385-97. PubMed ID: 11713275
[TBL] [Abstract][Full Text] [Related]
16. [The influence of neuroendocrine differentiation on the growth and androgen receptor expression of prostate carcinoma cells].
Song Y; Wu G; Xin DQ; Na YQ
Zhonghua Wai Ke Za Zhi; 2004 Dec; 42(23):1453-6. PubMed ID: 15733464
[TBL] [Abstract][Full Text] [Related]
17. GRP receptor-mediated immediate early gene expression and transcription factor Elk-1 activation in prostate cancer cells.
Xiao D; Qu X; Weber HC
Regul Pept; 2002 Nov; 109(1-3):141-8. PubMed ID: 12409226
[TBL] [Abstract][Full Text] [Related]
18. VIP and PACAP are autocrine factors that protect the androgen-independent prostate cancer cell line PC-3 from apoptosis induced by serum withdrawal.
Gutiérrez-Cañas I; Rodríguez-Henche N; Bolaños O; Carmena MJ; Prieto JC; Juarranz MG
Br J Pharmacol; 2003 Jul; 139(5):1050-8. PubMed ID: 12839880
[TBL] [Abstract][Full Text] [Related]
19. The human prostatic carcinoma cell line LNCaP and its derivatives. An overview.
van Steenbrugge GJ; Groen M; van Dongen JW; Bolt J; van der Korput H; Trapman J; Hasenson M; Horoszewicz J
Urol Res; 1989; 17(2):71-7. PubMed ID: 2660395
[TBL] [Abstract][Full Text] [Related]
20. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
Murthy S; Agoulnik IU; Weigel NL
Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]